Abstract
INTRODUCTION

51
Cellular senescence is an important risk factor for cardiovascular diseases, such as as an internal control, as described previously (40) . After transfection for 24 h, cells
141
were incubated with Ang II, Exendin-4 or Ang II in combination with Exendin-4.
142
Luciferase activity was measured using the Reporter Luciferase assay kit (Promega)
143
and β-galactosidase activity was measured using O-nitrophenyl β-galactopyranoside.
144
Variations in transfection efficiency were normalized using β-galactosidase activity. proteins showed that phosphorylation of γ-H2AX was induced by Ang II at 1 h, which 205 even increased over 24 h (Fig. 1B) . In parallel to the SA β-galactosidase staining,
206
Exendin-4 significantly attenuated Ang II-induced superoxidant production using the
207
Amplex Red assay (Fig. 1C) . 2D), with its effects peaking at 1 h (Fig. 2D ).
227
The phosphorylation of Nrf2 was also investigated, as it has been reported to 228 play a critical role in the dissociation of Nrf2 from Keap1 and nuclear distribution of responsive element. ARE activity at 6 h was increased by Ang II (Fig. 2F ). However,
234
the increase in mean ARE activation was not significant. At 12 h and 24 h, ARE 235 activity were almostly not affected by Ang II (Fig. 2F ), but at the same time,
236
Exendin-4 alone treatment increased the ARE activity compared with control ( not affected (Fig. 2G ). Exendin-4 may markedly increase the protein levels of HO-1
242
and NQO-1 in the presence or absence of Ang II (Fig. 2G) . The combination of
243
Exendin-4 and Ang II increased the protein levels of NQO-1 and HO-1 dose-and 244 time-dependently (Fig. 2H) . reported that Exendin-4 increased the phosphorylation of PKA (Fig. 4B) . Moreover,
271
Exendin-4 significantly induced the phosphorylation of CREB on Ser133 (Fig. 4B ),
272
which was blunted by PKA inhibitor PKI14-22 (Fig. 4C) .
273
To identify a connection between cAMP/PKA and Exendin-induced Nrf2/ARE Exendin-4-induced ARE4-luc activation in VSMCs exposed to Ang II.
277
In addition, the upregulations of HO-1 and NQO-1 induced by Exendin-4 were 278 also reduced by either PKI14-22 or CREB siRNA (Fig. 4, E and F that Nrf2 acetylation was not significantly observed in Ang II-treated cells (Fig. 5A ),
287
whereas Exendin-4 increased the acetylation of Nrf2 dose-dependently (Fig. 5B) . The 288 whole cell content of Nrf2 was not changed by Exendin-4. These results provide 289 strong support for our hypothesis that Exendin-4 could induce changes in the 290 acetylation status of Nrf2, not changes in the whole cell content of Nrf2.
291
The key cofactor related to cAMP-mediated signaling that has been associated Ang II had no effect on the recruitment of p300, CBP or PCAF to Nrf2. In the
299
Exendin-4 treatment group, increased Nrf2 was specifically detected with anti-Nrf2 300 antibody in the immunoprecipitate made by anti-CBP antibody, but not in the p300,
301
PCAF, or control IgG immunoprecipitates (Fig. 5D ). CBP expression remained 302 unchanged after Exendin-4 treatment. Therefore, CBP was the most potent in 303 acetylating Nrf2 in reponse to Exendin-4 and was chosen for the subsequent studies.
304
In addition, the Exendin-4-stimulated acetylation of Nrf2 was reduced by the addition
305
Exendin-4 suppresses VSMC senescence via Nrf2 activation 17 of PKA inhibitor PKI14-22 (Fig. 5E ). Pretreatment with GLP-1R antagonist Exendin
306
(9-39) or PKI14-22 decreased the binding of Nrf2 and CBP (Fig. 5F ).
308
CBP is essential for Exendin-4-mediated Nrf2 acetylation and nulear translocation.
309
To establish a functional role for CBP in Exendin-4-mediated acetylation of Nrf2,
310
RNAi was employed. As shown in Fig. 6A , CBP knockdown greatly decreased 311 nuclear CBP expression in VSMCs. Importantly, the Exendin-4-induced acetylation
312
of Nrf2 was reduced in the presence of CBP siRNA (Fig. 6B ).
313
To assess the nucleocytoplasmic redistribution of Nrf2 under conditions of (Fig. 7, A and B VSMCs. CREB phosphorylation was detectable within 2 min after treatment of
458
VSMCs with 100 nM Ang II, and returned to basal levels after 15 min (Fig. 4A) It has been hypothesised that, vascular smooth muscle cell senescence promotes 479 the thinning of fibrous caps and the instability of atherosclerotic plaques (16).
480
Telomere dysfunction is involved in replicative and stress-induced senescence (13).
481
Telomere shortening might be an independent risk factor for atherosclerosis through 
